A crackdown on corruption in China’s pharmaceutical sector has hurt sales at international and local firms, with many doctors at Chinese hospitals refusing to see drug representatives for fear of being caught up in the widening scandal. Britain’s GlaxoSmithKline Plc, the group at the center of the furore, has […]